Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy

The past decade has witnessed the explosive development of cancer immunotherapies. Nevertheless, low immunogenicity, limited specificity, poor delivery efficiency, and off‐target side effects remain to be the major limitations for broad implementation of cancer immunotherapies to patient bedside. En...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Shaobo, Huang, Yuanyu, He, Mei, Gao, Huile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165523/
https://www.ncbi.nlm.nih.gov/pubmed/35343112
http://dx.doi.org/10.1002/advs.202200027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165523/
https://www.ncbi.nlm.nih.gov/pubmed/35343112
http://dx.doi.org/10.1002/advs.202200027

Ejemplares similares